Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Facebook
LinkedIn
Fill out the form below to download this content.
Leveraging-a-Humanized-SLE-Mouse-Model-to-Evaluate-Next-Generation-Immune-Cell-Targeted-Therapeutics

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics

Name(Required)
By clicking submit you consent to receive email communications about products and services of Medicilon and are in accordance with our Privacy Policy. You may opt out at any time.

Search Medicilon

Preclinical CRO

EFMC-ISMC 2026

Preclinical CRO

Medicilon Delivers One Stop Preclinical Support as Yizhong Pharma Secures NMPA Clinical Approval for YXC‑001 Tri‑functional Antibody Fusion Protein and YXC‑002 4th‑Generation EGFR Kinase Inhibitor

Preclinical CRO

4th SMC and AimedBio ADC Conference

Contact Medicilon

Name(Required)
Address(Required)